Cancer News and Research

Latest Cancer News and Research

New skin cancer drug successfully tested in humans

A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye diseases.

8 May 2013

Isis begins clinical study of ISIS-STAT3 in patients with metastatic liver cancer

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1b/2a clinical study of ISIS-STAT3Rx in patients with advanced metastatic hepatocellular carcinoma (HCC).

7 May 2013

Study says influenza immunization is safe in children with IBD

Influenza immunization rates in children with inflammatory bowel disease (IBD) are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences (ICES), Children's Hospital of Eastern Ontario (CHEO), the Ottawa Hospital Research Institute (OHRI), and the University of Ottawa.

7 May 2013

FDA warns over the use of sunlamp products that cause skin cancer

Today, the U.S. Food and Drug Administration issued a proposed order that, if finalized, would reclassify sunlamp products and require labeling to include a recommendation designed to warn young people not to use these devices.

7 May 2013

New gene implicated in Parkinson can delay onset of aging, extend life span

UCLA life scientists have identified a gene previously implicated in Parkinson's disease that can delay the onset of aging and extend the healthy life span of fruit flies. The research, they say, could have important implications for aging and disease in humans.

7 May 2013

TSRI announces five-year agreement with Janssen to research on influenza virus

The Scripps Research Institute (TSRI) today announced a five-year agreement with Janssen Pharmaceuticals, Inc. (Janssen) to collaborate on focused research projects in the infectious disease area, with the initial project targeting the influenza virus.

7 May 2013

AADA urges FDA to prohibit the use and sale of indoor tanning devices for minors

The American Academy of Dermatology Association (AADA) is pleased that the U.S. Food and Drug Administration (FDA) has proposed changes to its regulation of tanning beds, including a strong recommendation against the use of tanning beds by minors under the age of 18.

7 May 2013

Scientists halt tumour development through genetic manipulation of cytoskeleton in fly tissues

Cancer is a complex disease, in which cells undergo a series of alterations, including changes in their architecture; an increase in their ability to divide, to survive and to invade new tissues or metastasis.

7 May 2013

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

Aileron Therapeutics, Inc. today announced the completion of the first-in-human study of its lead Stapled Peptide drug, ALRN-5281, a proprietary, long-acting growth-hormone-releasing hormone (GHRH) agonist for treating orphan endocrine disorders, including adult growth hormone (GH) deficiency and human immunodeficiency virus (HIV) lipodystrophy, as well as broader patient populations involving a wide variety of metabolic/endocrine diseases.

7 May 2013

First Edition: May 7, 2013

Today's headlines include reports about two new studies exploring whether the slowdown in the nation's health spending growth rates is, in fact, due more to structural changes in the health ystem than to the economy.

7 May 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Kinase inhibitors are molecules that block the activity of kinases. Kinases are a specific class of enzymes. They are extremely important in signal transduction processes in the human body meaning that they actually regulate most of the physiological processes that take place in the body.

7 May 2013

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.

7 May 2013

Entremed reports patent issuance for its lead drug candidate ENMD-2076

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today announced the issuance by the Chinese State Intellectual Property Office of Patent Certificate No. ZL 200680044656.7.

7 May 2013

Aerobic exercise can help reduce breast cancer risk

Changes in estrogen breakdown, or metabolism, may be one of the mechanisms by which aerobic exercise lowers a woman's breast cancer risk, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

7 May 2013

CDC papers discuss approaches to reduce use of indoor tanning devices, prevent skin cancer

Preventing skin cancer by reducing use of indoor tanning devices requires a coordinated approach at the national, state, and local levels suggests a pair of papers by CDC authors in a special theme issue of the American Journal of Preventive Medicine. Evidence has shown that use of indoor tanning devices increases the risk of developing skin cancer, including melanoma, and these papers discuss approaches that could help reduce use of indoor tanning devices and prevent future incidence of skin cancers.

7 May 2013

Terminally ill patients supported by religious communities receive more-intensive EoL medical care

A study by Tracy A. Balboni, M.D., M.P.H., of the Dana-Farber Cancer Institute, Boston, and colleagues suggests that spiritual care and end-of-life (EoL) discussions by the medical team may be associated with reduced aggressive treatment.

7 May 2013

Minimal dose computed tomography better at detecting new or recurrent lung cancer

Lung cancer is associated with very high mortality, in part because it is hard to detect at early stages, but also because it can recur frequently after surgical removal.

7 May 2013

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.

7 May 2013

Roundup: Texas lawmakers quietly work to restore women's health services; brighter Calif. budget could mean new safety net cut fights

The political fireworks and high-octane drama that accompanied lawmakers' 2011 fight over women's health care and abortion has been absent this legislative session. It has been replaced with some semblance of concession, as legislators on both sides of the aisle work quietly to restore financing for women's health services.

7 May 2013

Men with severe sleep problems face increase risk of prostate cancer

Men who reported sleep problems, including difficulty falling asleep and staying asleep, had up to a twofold increased risk for prostate cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

7 May 2013

Cancer News and Research

Latest Cancer News and Research

New skin cancer drug successfully tested in humans

Isis begins clinical study of ISIS-STAT3 in patients with metastatic liver cancer

Study says influenza immunization is safe in children with IBD

FDA warns over the use of sunlamp products that cause skin cancer

New gene implicated in Parkinson can delay onset of aging, extend life span

TSRI announces five-year agreement with Janssen to research on influenza virus

AADA urges FDA to prohibit the use and sale of indoor tanning devices for minors

Scientists halt tumour development through genetic manipulation of cytoskeleton in fly tissues

Aileron Therapeutics concludes first-in-human study of ALRN-5281 Stapled Peptide drug

First Edition: May 7, 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

AUA and ASTRO release new guideline on adjuvant and salvage radiotherapy after prostatectomy

Entremed reports patent issuance for its lead drug candidate ENMD-2076

Aerobic exercise can help reduce breast cancer risk

CDC papers discuss approaches to reduce use of indoor tanning devices, prevent skin cancer

Terminally ill patients supported by religious communities receive more-intensive EoL medical care

Minimal dose computed tomography better at detecting new or recurrent lung cancer

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Roundup: Texas lawmakers quietly work to restore women's health services; brighter Calif. budget could mean new safety net cut fights

Men with severe sleep problems face increase risk of prostate cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in